Difference between revisions of "Glycoprotein non-metastatic B"

From Libre Pathology
Jump to navigation Jump to search
(carete)
Line 10: Line 10:
*[[Low-grade oncocytic tumour]] (LOT).
*[[Low-grade oncocytic tumour]] (LOT).
*[[PEComa]].
*[[PEComa]].
*[[RCC with FMS]].
*[[RCC with fibromyomatous stroma]].


==References==
==References==

Revision as of 13:28, 26 March 2024

Glycoprotein non-metastatic B, abbreviated GPNMB, is an immunostain.

It is typically positive in TSC1/TSC2/MTOR mutated renal cell carcinomas.[1]


Positive

References

  1. Li H, Argani P, Halper-Stromberg E, Lotan TL, Merino MJ, Reuter VE, Matoso A (November 2023). "Positive GPNMB Immunostaining Differentiates Renal Cell Carcinoma With Fibromyomatous Stroma Associated With TSC1/2/MTOR Alterations From Others". Am J Surg Pathol 47 (11): 1267–1273. doi:10.1097/PAS.0000000000002117. PMID 37661807.